A single dose study of R1450 in patients with Alzheimer disease

Trial Profile

A single dose study of R1450 in patients with Alzheimer disease

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Feb 2010

At a glance

  • Drugs Gantenerumab (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 08 Dec 2008 Status changed from active, no longer recruiting to completed.
    • 11 Jan 2008 Status changed from recruiting to in progress.
    • 01 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top